Clinical trial
An Open-Label, Multi-Center Study to Evaluate the Safety of Long-Term Administration of TAK-128 in Subjects With Mild to Moderate Diabetic Peripheral Neuropathy
NCT00756041 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Multi-Center Study to Evaluate the Safety of Long-Term Administration of TAK-128 in Subjects With Mild to Moderate Diabetic Peripheral Neuropathy
- Lead sponsor
- Takeda
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 30, 2005
- Completion date
- September 30, 2006
- Enrollment
- 221 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.